COPD trials in Russia

1 of 7 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Enrolling by invitation
  Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency

  Where

  Barnaul

  Age

  20 years to 72 years

  People

  290 worldwide

  Run by

  Grifols Therapeutics LLC

  See details and how to joinNCT02796937